Cited by 937COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchMalaria Research and Control

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Open access

Colson, Philippe, Rolain, Jean-Marc, Lagier, Jean-Christophe, Brouqui, Philippe, Raoult, Didier·2020·International Journal of Antimicrobial Agents

DOI 10.1016/j.ijantimicag.2020.105932PMC PMC7135139

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ijantimicag.2020.105932

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731
Whipple's Disease
Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651
Self-citation
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644
New insights into the antiviral effects of chloroquine
Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471
Self-citation
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Rolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408
Self-citation

Show all 26 references

Sorted by citations

Items 501–600 of 937

Coronavirus Disease-19 and Rheumatological Disorders: A Narrative Review
Chattopadhyay, A., Mishra, D., Sharma, V. M., Naidu, G., & Sharma, A. (2020) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_73_20 · Cited by 7
An open‐label cluster‐randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID‐19 (ARCHAIC)—Protocol publication
Weehuizen, J. M., & Hoepelman, A. I. M. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13297 · Cited by 7
Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations
Pham, P. V., & Vu, N. B. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i8.721 · Cited by 7
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
Stanković, B., Kotur, N., Gašić, V., Klaassen, K., Ristivojević, B., Stojiljković, M., Pavlović, S., & Zukić, B. (2020) · Journal of Medical Biochemistry · doi:10.5937/jomb0-26725 · Cited by 7
Therapeutic Options Against the New Coronavirus: Updated Clinical and Laboratory Evidences
Fernandes, A. C. L., Vale, A. J. M., Gúzen, F. P., Pinheiro, F. I., Cobucci, R. N., & de Azevedo, E. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00546 · Cited by 7
Basic Critical Care for Management of COVID-19 Patients: Position Paper of Indian Society of Critical Care Medicine, Part-I
Singh, M., Ramasubban, S., Juneja, D., Reddy, P. K., Gopal, P. B. N., Savio, R. D., & Dixit, S. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23601 · Cited by 7
Investigating the factors affecting the survival rate in patients with COVID-19: A retrospective cohort study.
Eshrati, B., Baradaran, H. R., Erfanpoor, S., Mohazzab, A., & Moradi, Y. (2020) · PubMed Central · doi:10.34171/mjiri.34.88 · Cited by 7
Comprehensive Literature Review and Evidence evaluation of Experimental Treatment in COVID 19 Contagion
Boregowda, U. N., Gandhi, D., Jain, N. K., Khanna, K., & Gupta, N. (2020) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.1177/1179548420964140 · Cited by 7
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
Kooshkaki, O., Derakhshani, A., Conradie, A. M., Hemmat, N., Barreto, S. G., Baghbanzadeh, A., Singh, P. K., Safarpour, H., Asadzadeh, Z., Najafi, S., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572329 · Cited by 7
Computational modeling of the pharmacological actions of some antiviral agents against SARS-CoV-2
Adegboyega, A. E., Johnson, T. O., & Omale, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824536-1.00018-6 · Cited by 7
Virtual Screening of Plant Metabolites against Main protease, RNA-dependent RNA polymerase and Spike protein of SARS-CoV-2: Therapeutics option of COVID-19Preprint
Parvez, M. S. A., Azim, K. F., As, I., Raihan, T., Begum, A., Shammi, T. S., Howlader, S., Bhuiyan, F. R., & Hasan, M. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2005.11254 · Cited by 6
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCSPreprint
O'Donovan, S. M., Eby, H., Henkel, N., Creeden, J. F., Imami, A. S., Asah, S. M., Zhang, X., Wu, X., Alnafisah, R. S., Taylor, R. T., et al. (2020) · doi:10.21203/rs.3.rs-25643/v1 · Cited by 7
Observational Study on 255 Mechanically Ventilated Covid Patients at the Beginning of the USA PandemicPreprint
Smith, L. G., Mendoza, N., DOBESH, D. P., & Smith, S. M. (2021) · medRxiv · doi:10.1101/2021.05.28.21258012 · Cited by 7
Evaluation of antiviral potential of Cinchona officinalis derived compounds against COVID-19 and human hepatitis B: An in silico molecular docking and molecular dynamics simulation study
Mulongo, E. K., Matondo, A. P., Ngbolua, K.-T.-N., & Mpiana, P. T. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100229 · Cited by 6
An overview of potential therapeutic agents to treat COVID-19
Dong, X., Tian, Z., Shen, C., & Zhao, C. (2020) · BioScience Trends · doi:10.5582/bst.2020.03345 · Cited by 6
Low-Dimensional Compounds Containing Bioactive Ligands. Part XX: Crystal Structures, Cytotoxic, Antimicrobial Activities and DNA/BSA Binding of Oligonuclear Zinc Complexes with Halogen Derivatives of 8-Hydroxyquinoline
Harmošová, M., Kello, M., Goga, M., Tkáčiková, Ľ., Vilková, M., Sabolová, D., Sovová, S., Samoľová, E., Litecká, M., Kuchárová, V., et al. (2023) · Inorganics · doi:10.3390/inorganics11020060 · Cited by 6
The Computational Intervention of Macrolide Antibiotics in the Treatment of COVID-19
Anwar, F., Altayb, H. N., Al-Abbasi, F. A., Kumar, V., & Kamal, M. A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210125121954 · Cited by 6
COVID-19 and immune-mediated inflammatory rheumatic diseases
Nasonov, E. L. (2021) · Clinical pharmacology and therapy · doi:10.32756/0869-5490-2021-1-24-29 · Cited by 6
COVID‐19: Patient care after discharge from the Intensive Care Unit
Chadli, A., Haraj, N. E., Aziz, S. E., Laidi, S., Mounir, A., Bensbaa, S., Mjabber, A., Barrou, L., Kettani, C. E., Nsiri, A., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14270 · Cited by 6
Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?
Mustafa, D. A. M., Saida, L., Latifi, D., Wismans, L. V., de Koning, W., Zeneyedpour, L., Luider, T. M., van den Hoogen, B. G., & van Eijck, C. H. J. (2021) · Cancers · doi:10.3390/cancers13122896 · Cited by 6
Current Potential Options for COVID-19 Treatment in Iraq- Kurdistan Region and the Rest of the World: A Mini-review
Faraj, A. M., Qadir, S. A., Mohammed, O. A., Aziz, P. Y., Alkhafaji, M., Rahman, H. S., Aziz, J. M. A., Othman, H. H., & AL-Zubaidy, A. M. A. (2022) · Iraqi Journal of Science · doi:10.24996/ijs.2022.63.3.4 · Cited by 6
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study
Hong, W., Park, Y., Kim, B.-O., Park, S. K., Shin, J., Jang, S.-P., Park, H.-W., Yang, W., Jang, J., Jang, S.-W., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267645 · Cited by 6
Physiologically-Based Pharmacokinetics Modeling for Hydroxychloroquine as a Treatment for Malaria and Optimized Dosing Regimens for Different Populations
Zhai, J., Ji, B., Cai, L., Liu, S., Sun, Y., & Wang, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050796 · Cited by 6
Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders
Sadeghi, P., Pezeshki, P. S., & Rezaei, N. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-04958-6 · Cited by 6
The COVID-19 Pandemic and Planetary Health. A Critical Review of Epidemiology, Prevention, Clinical Characteristics and Treatments for Oral, Head and Neck Health Professionals. Do We Have a Roadmap?
Jotz, G., Stein, A., Sirena, S., Barros, E., Baldisserotto, J., de Figueiredo, J. D., Lavinsky, J., Steier, L., & Dora, C. (2020) · International Archives of Otorhinolaryngology · doi:10.1055/s-0040-1714143 · Cited by 6
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Ahmadinejad, Z., Assari, R., Yazdi, N. A., Mazloomi, S.-H., Javanshayani, P., Afousi, H. K., & Ziaee, V. (2020) · Reumatismo · doi:10.4081/reumatismo.2020.1289 · Cited by 6
The Demographic and Clinical Features of 479 COVID-19 Patients: A Single-Center Experience
Ersan, G., Bac, G. A., Yüksel, Ö., Papila, F. S. C., Papila, Ç., Arsu, G., Ozcukurlu, A. R., Aktas, O., Ersan, S., İnan, A. H., et al. (2020) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.galenos.2020.2020.9 · Cited by 6
Familiar dermatologic drugs as therapies for COVID-19
Ortega-Peña, M., & González‐Cuevas, R. (2020) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2020.09.015 · Cited by 6
Anthraquinolone and quinolizine derivatives as an alley of future treatment for COVID-19: an in silico machine learning hypothesis
Samarth, N. H., Kabra, R., & Singh, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-97031-x · Cited by 6
Facile synthesis of dual-emission fluorescent carbon nanodots for a multifunctional probe
Cheng, C.-W., Lo, K.-M., Li, M.-F., Chiu, T., & Hu, C.-C. (2021) · RSC Advances · doi:10.1039/d1ra07826g · Cited by 6
Inhibitory effect of compounds extracted from Monochoria hastata (L.) Solms on SARS-CoV-2 main protease: An insight from molecular docking and MD-simulation studies
Baildya, N., Ghosh, N. N., Chattopadhyay, A. P., Mandal, V., Majumdar, S., Ansary, D., & Sarkar, M. M. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.132644 · Cited by 6
Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update
Joshi, G., Thakur, S., Mayank, M., & Ramarao, P. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112106 · Cited by 6
The molecular dynamics of possible inhibitors for SARS-CoV-2
Irani, A. H., Steyn‐Ross, D. A., Steyn‐Ross, M. L., Voss, L. J., & SLEIGH, J. W. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1942215 · Cited by 6
The Role of Hyaluronic Acid in Tissue Engineering
Collins, M. N., Zamboni, F., Serafin, A., Ren, G., Thanusha, A. V., & Culebras, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-42215-8_56 · Cited by 6
Potential Drug Candidates Underway Several Registered Clinical Trials for Battling COVID-19Preprint
Mina, F. B., Rahman, M., Das, S., Karmakar, S., & Billah, M. (2020) · doi:10.22541/au.158949149.99681139 · Cited by 6
Theoretical Investigation of (E)-1-(2,4-Dichlorophenyl)-3-[4-(morpholin-4-yl)phenyl]prop-2-en-1-one Molecule As a Possible Potential COVID-19 Drug Candidate: Molecular Docking and DFT Calculations
Ekíncíoğlu, Y. (2023) · Russian Journal of Physical Chemistry A · doi:10.1134/s0036024423130241 · Cited by 5
Uso de antipalúdicos en el tratamiento del COVID-19: ¿una ventana de oportunidad?
Lasheras, I., & Santabárbara, J. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.04.004 · Cited by 5
Theoretical Prediction of Possible Drug Treatment of COVID-19 using Coumarins Containing Chloroquine Moeity
Ibrahim, A. A., Yahya, O., & Ibrahim, M. A. (2020) · Asian Journal of Chemistry · doi:10.14233/ajchem.2020.22914 · Cited by 5
DETAILED VIEW ON REPURPOSED DRUGS, TRACKING OF VACCINES,AND BRIEF VIEW ON PROPHYLACTIC NANOMEDICINES AS AN ALTERNATIVE APPROACH AND PATIENT CARE FOR COVID-19
Nair, K. S., Kamath, S. R., Rajan, A., Thomas, S. B., Aswin, D., & Zachariah, S. M. (2021) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2021v13i1.39705 · Cited by 5
Spectrum of Respiratory Involvement in COVID 19 Era; An Overview
Jain, A. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i4.12644 · Cited by 5
A Review on Synthesis of Quinoline Analogs as Antimalarial, Antibacterial and Anticancer agents
Yadessa, A. M., & Zeleke, D. (2021) · Ethiopian Journal of Science and Sustainable Development · doi:10.20372/ejssdastu:v8.i2.2021.368 · Cited by 5
COVID-19: well-known drugs, new opportunities
Uzbekistan’s Public Healthcare Ministry, 2. S. S., Хамидович, А. А., Мавлянов, И. Р., Искандарович, М. З., & Жарылкасынова, Г. Ж. (2020) · Health Risk Analysis · doi:10.21668/health.risk/2020.4.19 · Cited by 4
QSPR Analysis of Some Phenolic Compounds Present in Moringa Oleifera
Yang, J., Siddiqui, M. K., Hussain, M., Manzoor, S., Hussain, N., & Saddique, Z. (2023) · Polycyclic aromatic compounds · doi:10.1080/10406638.2023.2247120 · Cited by 5
Efficacy of Quinine Sulfate in Patients with Mild-To-Moderate COVID-19: A Randomized Controlled Trial
Latarissa, I. R., Barliana, M. I., Meiliana, A., Sormin, I. P., Sugiono, E., Kartasasmita, C. B., Irmansyah, I., & Lestari, K. (2023) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v15i6.2543 · Cited by 5
COVID-19 (An International Trauma): A Brief Analysis on Research Trends, Impacts and Solutions
Sharma, M. (2020) · International Journal for Research in Applied Sciences and Biotechnology · doi:10.31033/ijrasb.7.2.1 · Cited by 5
COVID-19: Off-label therapies based on mechanism of action while waiting for evidence-based medicine recommendations
Vetta, M. S. D., Morrone, M., & Fazio, S. (2020) · World Journal of Meta-Analysis · doi:10.13105/wjma.v8.i3.173 · Cited by 5
Why nobody discusses the adverse psychiatric effects of chloroquine in case it might become the future treatment against COVID ‐19?
Nessaibia, I., Dafne, S., & Tahraoui, A. (2020) · The International Journal of Health Planning and Management · doi:10.1002/hpm.3057 · Cited by 5
Bail-out extracorporeal membrane oxygenation for hydroxychloroquine intoxication: a warning for COVID-19 health-care givers
Holvoet, W., van Soest, K., Havenith, T., Lorusso, R., van Mook, W., & Delnoij, T. (2020) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2020.1802903 · Cited by 5
A Study on Novel Corona Virus Disease (COVID-19)
Singh, H., Kumar, S., & Kumar, R. (2021) · Asian Journal of Engineering and Applied Technology · doi:10.51983/ajeat-2021.10.1.2801 · Cited by 5
Metabolome and exposome profiling of the biospecimens from COVID-19 patients in India
Aggarwal, S., Parihari, S., Banerjee, A., Roy, J., Banerjee, N., Bankar, R., Kumar, S., Choudhury, M., Shah, R., Bhojak, K., et al. (2021) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-161 · Cited by 5
Low-dimensional compounds containing bioactive ligands. Part XXI: Crystal structures, cytotoxic, antimicrobial activities and BSA binding of zinc complexes with 5-chloro-7-nitro-8-hydroxyquinoline
Harmošová, M., Kello, M., Goga, M., Frenák, R., Tkáčiková, Ľ., Vilková, M., Sabolová, D., Sovová, S., Samoľová, E., & Potočňák, I. (2023) · Polyhedron · doi:10.1016/j.poly.2023.116347 · Cited by 5
A Hemodialysis Patient with Severe COVID-19 Pneumonia
Alalwan, A. A., Taher, A., & Al-Aradi, A. (2020) · Cureus · doi:10.7759/cureus.7995 · Cited by 5
Farmakoterápiás lehetőségek SARS-CoV-2-fertőzés/COVID–19-betegség esetén
Fábián, Á., László, I. P., Juhász, M., Berhés, M., Végh, T., Koszta, G., Molnár, C., & Fülesdi, B. (2020) · Orvosi Hetilap · doi:10.1556/650.2020.31812 · Cited by 5
Can antimalarial, antiviral and anti-respiratory infections Cameroonian medicinal plants be used as one of the potential ways to cure COVID-19? Pharmacological and ethnomedicinal proof
Roger, T., Yougouda, H., Guidawa, F., Tatsimo, S. J. N., Avana, M.-L., Taffo, J. B. W., Marie, M. P., & Patrick, V. D. (2020) · Journal of Medicinal Herbs and Ethnomedicine · doi:10.25081/jmhe.2020.v6.6240 · Cited by 5
Epidemic Characteristics of COVID-19 in Africa
Wang, L., Dong, S., Zhao, Y., Gao, Y., Wang, J., Yu, M., Xu, F., & Chai, Y. (2020) · Frontiers in Physics · doi:10.3389/fphy.2020.564698 · Cited by 5
Current Therapeutic Interventions for COVID-19
Arsoy, H. E. M., & Özdemır, Ö. (2020) · Bezmialem Science · doi:10.14235/bas.galenos.2020.4758 · Cited by 5
Natural and semisynthetic candidate molecules for COVID-19 prophylaxis and treatment
Biţă, A., Scorei, I. R., Mogoantă, L., Bejenaru, C., Mogoşanu, G. D., & Bejenaru, L. E. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.2.02 · Cited by 5
COVID-19 Infection: Targeting Possibilities for Treatment
Haider, T., Gour, V., Pandey, V., Kanwar, I. L., Tiwari, R., Vishwakarma, M., Bakshi, A. K., Sarkar, A., Yadav, R., Soni, S., et al. (2021) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2021035392 · Cited by 5
Highlights on Evidence-Based Treatment Strategies for COVID-19: a Review
(2020) · Letters in Applied NanoBioScience · doi:10.33263/lianbs93.13591371 · Cited by 5
Investigating the factors affecting the survival rate in patients with COVID-19: A retrospective cohort study
Eshrati, B., Baradaran, H. R., Erfanpoor, S., Mohazzab, A., & Moradi, Y. (2020) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.34.88 · Cited by 5
Open Questions for Harnessing Autophagy-Modulating Drugs in the SARS-CoV-2 WarPreprint
Brest, P., Benzaquen, J., Klionsky, D. J., Hofman, P. M., & Mograbi, B. (2020) · Preprints.org · doi:10.20944/preprints202004.0022.v1 · Cited by 5
РОЛЬ ДЕЗИНТОКСИКАЦИОННОЙ И АНТИОКСИДАНТНОЙ ТЕРАПИИ В ЛЕЧЕНИИ COVID-19: ТЕОРИЯ И ПРАКТИКАPreprint
Александровна, Х. Д., Ruzhentsova, T. A., Chukhliaev, P. V., Александрович, Г. А., & Константиновна, Ш. Е. (2020) · doi:10.21055/preprints-3111722 · Cited by 5
Exploring Drug Repurposing for Influenza A (H3N2) Virus: A Computational Approach to Identifying Commercialized Drugs Targeting Hemagglutinin, Neuraminidase, and Nucleoprotein
Mounadi, N., Nour, H., Abass, K. S., Kouali, M. E., & Chtita, S. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00992 · Cited by 4
COVID-19: A Review of the Pandemic with Emphasis on the Role of Imaging
Bothra, M., Shera, T. A., Bajpai, J., & Mahajan, A. (2020) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/ijmpo.ijmpo_223_20 · Cited by 4
Management of Patients with Connective Tissue Disease-associated Interstitial Lung Diseases During the COVID-19 Pandemic
Gurkan, C. G., Karadoğan, D., Ufuk, F., Cüre, O., & Altınışık, G. (2021) · Turkish Thoracic Journal · doi:10.5152/turkthoracj.2021.20172 · Cited by 4
Repurposed Drugs during the Outbreak of Pandemic COVID-19: A Mini-Review on Their Molecular Structures and Hit-and-Trial Results
Devi, T. L., Devi, M. M., Okram, M., & Singh, O. M. (2024) · ACS Omega · doi:10.1021/acsomega.4c05357 · Cited by 4
Utility of Hypertonic Saline and Diazepam in COVID-19–Related Hydroxychloroquine Toxicity
Mahan, K. M., Hayes, B. D., North, C. M., Becker, J. S., Fenves, A. Z., Hyppolite, G., Khosrowjerdi, S., Sinden, D. S., & Stearns, D. A. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.10.048 · Cited by 4
Mechanism of Action of Chloroquine/Hydroxychloroquine for Covid-19 Infection
Boretti, A. A., Banik, B. K., & Castelletto, S. (2020) · Coronaviruses · doi:10.2174/2666796701999201112125319 · Cited by 4
HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers
Jha, S., Batra, N., Siddiqui, S., Yadav, A., Misra, A., Loomba, M., Sethi, S., & Waghdhare, S. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.11.005 · Cited by 4
Evaluating the Efficacy and Safety of the Existing Repurposed Pharmacological Agents for Treating COVID-19: A Meta-analysis and Systematic Review of Clinical Trials
Choupoo, N. S., Das, S. K., Haldar, R., Sarkar, H., Tewari, R., & Ray, S. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23664 · Cited by 2
The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course
Бобкова, Н. В. (2021) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747821010037 · Cited by 4
Impact of COVID-19 on Advanced Cancer Patients’ Pain Care: Warning About Chloroquine and Hydroxychloroquine
Aminnejad, R., Hashemi, S. M., Safari, S., Dadkhah, P., & Bastanhagh, E. (2021) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.111641 · Cited by 4
Knowledge and perceptions of pharmacists’ readiness during coronavirus pandemic: the case of United Arab Emirates
Basheti, I. A., Mhaidat, N. M., Al-Azzam, S. I., Alqudah, R., Nassar, R. I., Alzubaidi, H., Abu‐Samak, M., & Abu‐Gharbieh, E. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00382-z · Cited by 4
Recent Advances in Understanding SARS-CoV-2 Infection and Updates on Potential Diagnostic and Therapeutics for COVID-19
Mukherjee, M. D., Kumar, A., Solanki, P. R., Verma, D., Yadav, A. K., Chaudhary, N., & Kumar, P. (2022) · Coronaviruses · doi:10.2174/2666796703666220302143102 · Cited by 4
Poor regulation, desperation, and misinformation, a countrywide analysis of self-medication and prescription patterns in Ecuador during the COVID-19 pandemic
Ortiz‐Prado, E., Izquierdo‐Condoy, J. S., Mora, C., Vásconez-González, J., & Fernández-Naranjo, R. (2023) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2023.08.011 · Cited by 6
Neurotoxic effects of chloroquine and its main transformation product formed after chlorination
Hu, S., Zhao, J. Y., Fang, S., Guo, K., Qi, W., & Liu, H. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168043 · Cited by 4
Coronavirus Disease 2019 (COVID‐19): Morocco Interrupting the Transmission by Ethics, Logistics, and Therapeutics Efforts
Baz, S. E., & Imziln, B. (2020) · Journal of Clinical and Experimental Investigations · doi:10.5799/jcei/8214 · Cited by 4
Современная пандемия COVID-19 и лекарственные средства
Фисенко, В. П., & Chichkova, N. V. (2020) · Экспериментальная и клиническая фармакология · doi:10.30906/0869-2092-2020-83-4-43-44 · Cited by 4
Exploring pathophysiology of COVID-19 infection: Faux espoir and dormant therapeutic options
Nikhra, V. (2020) · International Journal of Clinical Virology · doi:10.29328/journal.ijcv.1001013 · Cited by 4
A Perspective Study on Oral-fecal Transmission of COVID-19, its Prevention and Management
Abdullah, A., Faisal, S., Jan, H., Zainab, R., Khan, A., Rahman, A. U., Bibi, B., & Ishaq, H. (2020) · International Cardiovascular Forum Journal · doi:10.17987/icfj.v20i0.695 · Cited by 4
Modulation of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in receptor, innate immunity and drug antiviral candidate
Tarigan, I. L., & Arum, K. (2020) · Jurnal Teknologi Laboratorium · doi:10.29238/teknolabjournal.v9i1.214 · Cited by 4
MOLECULAR DOCKING STUDY OF NOVEL COVID-19 PROTEASE WITH CURRENT CLINICAL MANAGEMENT AGENTS
Wadhwa, P. K. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i9.38501 · Cited by 4
The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection
Kobak, Ş. (2020) · Current Rheumatology Reviews · doi:10.2174/1573397116666201029155105 · Cited by 4
A strategy of traditional Chinese medicine against COVID-19: linking current basic research and ancient medicine texts
Chen, C., Kwong, P. C., & Lin, Y. (2020) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2020.13.00497 · Cited by 4
Towards a more effective strategy for COVID‑19 prevention (Review)
Szkaradkiewicz, A. K., & Szkaradkiewicz, A. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9465 · Cited by 4
Impact of feed restriction, chloroquine and deoxynivalenol on viral haemorrhagic septicaemia virus IVb in fathead minnow Pimephales promelas Rafinesque
Liu, J., & Lumsden, J. S. (2020) · Journal of Fish Diseases · doi:10.1111/jfd.13300 · Cited by 4
Plasmapheresis with corticosteroids and antiviral: a life-saving treatment for severe cases of Covid 19.
Bagherzadeh, M., Parham, M., Zohali, S., Molaei, S., & Vafaeimanesh, J. (2020) · Europe PMC (PubMed Central) · doi:10.22088/cjim.11.0.572 · Cited by 4
The COVID-19 Pandemic: Data Analysis, Impacts and Future Considerations
Parvizi, P., Jalilian, M., Parvizi, H., Amiri, S., & Doust, H. M. (2021) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.15.1.1 · Cited by 4
Fármacos de uso frecuente en dermatología como terapia para COVID-19
Ortega-Peña, M., & González‐Cuevas, R. (2020) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2020.09.004 · Cited by 4
Molecular in silico docking interventions in various SARS-CoV-2 receptor targets involving bioactive herbal compounds of Andrographis paniculata (Burm. f.) Nees against COVID-19
Sahithya, M. D., Srinath, M., Kumar, B. C., & Giri, C. C. (2021) · Annals of Phytomedicine An International Journal · doi:10.21276/ap.covid19.2021.10.1.4 · Cited by 5
Therapeutic Agents Against COVID-19 with Clinical Evidence
Tian, C., & Xiang, M. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210114150951 · Cited by 4
The Current Understanding and Potential Therapeutic Options to Combat COVID-19Preprint
Subash, S., Pandit, S., & Nagendra, H. G. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3759166 · Cited by 4
Chloroquine and hydroxychloroquine as antimalarials and antivirals against SARS-CoV-2: The hemin factorPreprint
Herraiz, T. (2020) · doi:10.31219/osf.io/8d6xv · Cited by 4
Copper(II) complexes of 8-hydroxyquinoline derivatives: alternative methods for obtaining crystals suitable for X-ray structural analysis
Kepeňová, M., Samoľová, E., Smolková, R., & Potočňák, I. (2025) · Transition Metal Chemistry · doi:10.1007/s11243-025-00666-2 · Cited by 3
A high-throughput response to the SARS-CoV-2 pandemic
Rasmussen, L. A., Sanders, S. K., Sosa, M. I., McKellip, S. N., Nebane, N. M., Martinez-Gzegozewska, Y., Reece, A. J., Ruiz, P., Manuvakhova, A., Zhai, L., et al. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.100160 · Cited by 3
Comprehensive review on repurposing of approved medicine in the management of COVID-19 infection
Patel, D., Shah, U., Patel, A., Patel, S. P., Patel, M. M., Patel, A. D., Patel, S., Solanki, N. D., & Pandey, N. O. (2022) · Organic Communications · doi:10.25135/acg.oc.117.2110.2244 · Cited by 3
Indicação e uso de azitromicina no tratamento do COVID-19: revisão da literatura / Indication of azithromycin in the treatment of COVID-19: literature review
Moura, J. M. D., Silva, L. M., Souza, R. F. D., & Ramos, D. V. B. (2021) · Brazilian Journal of Development · doi:10.34117/bjdv7n6-185 · Cited by 3
Natural drugs for the treatment of severe acute respiratory syndrome coronaviruses infections (SARS-CoV and COVID-19)
Bachir, Y. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95578-2.00014-5 · Cited by 3
Low-dimensional compounds containing bioactive ligands. Part XXIII: A comprehensive study of the preparation and cytotoxic activities of zirconium(IV) complexes with 8-hydroxyquinoline and its derivatives
Harmošová, M., Vilková, M., Kello, M., Šebová, D., Samoľová, E., Litecká, M., & Potočňák, I. (2023) · Polyhedron · doi:10.1016/j.poly.2023.116794 · Cited by 3
Hydroxychloroquine: Pharmacokinetics and Toxicity
Brouqui, P., Chabrière, É., & Raoult, D. (2024) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/2024/6500340 · Cited by 3
Self-citation

Authors: Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D.
Affiliations: Aix-Marseille Université (FR)
Corresponding author: Raoult, Didier
ORCID: Colson, Philippe
Rolain, Jean-Marc
Lagier, Jean-Christophe
Brouqui, Philippe
Raoult, Didier
Venue: International Journal of Antimicrobial Agents
Publisher: Elsevier BV
Published: 2020-04
Volume: 55
Issue: 4
Pages: 105932
ISSN: 0924-8579 (ISSN-L)
DOI: 10.1016/j.ijantimicag.2020.105932
PMC: PMC7135139
OpenAlex: W3010277308
Cited by: 937
References: 26
Citations by year: 2026: 7 · 2025: 12 · 2024: 21 · 2023: 45 · 2022: 71 · 2021: 215 · 2020: 564
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (am, 386 d)
Locations: International Journal of Antimicrobial Agents (acceptedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Funders: Agence Nationale de la Recherche (ANR-10-IAHU-0003)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
Keywords: chloroquine, hydroxychloroquine, COVID-19 pandemic, SARS-CoV-2, antimalarial drugs, antiviral therapy
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Adenosine Monophosphate, Alanine, Chloroquine, Hydroxychloroquine, Pneumonia, Viral, Coronavirus, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks